Taken together, these data demonstrated that SOCS2 knockdown suppressed the tumorigenic capacity of HCT116 (p53−/−) cells in vivo, suggesting that SOCS2 may be related to tumor growth in colon cancer. The gene discussed is TP53; the disease is neoplasm.